Literature DB >> 12752783

Presence of functional vasopressin receptors in spinal ventral horn neurons of young rats: a morphological and electrophysiological study.

X Liu1, E Tribollet, R Ogier, C Barberis, M Raggenbass.   

Abstract

The objective of the present work was double. (i) Light microscopic autoradiography was used to determine the distribution of vasopressin and oxytocin binding sites in the spinal cord of rats. (ii) Whole-cell recordings were performed in lumbar spinal cord slices in order to assess whether these receptors are functional, whether they are located pre- or postsynaptically and whether they are present in motoneurons. In newborns, vasopressin binding sites of the V1a type were present in all laminae of the central gray at all segmental levels, whereas oxytocin binding sites were found only in the superficial layers of the dorsal horn. In adults, binding sites for both neuropeptides were also present, but were less dense. The dissociation constants for vasopressin were similar in newborns and adults. Whole-cell recordings showed that in identified motoneurons vasopressin exerted a direct effect, by inducing a membrane depolarization or by generating a sustained inward current, and an indirect effect, by enhancing glycinergic and GABAergic inhibitory transmission. Vasopressin-induced facilitation of inhibitory transmission could also be demonstrated in unidentified ventral horn neurons. All these effects were mediated by V1a but not V1b receptors. In some neurons, glycinergic transmission was also facilitated by a selective oxytocin receptor agonist. Our data, together with data obtained previously in brainstem motor nuclei, suggest that vasopressin of hypothalamic origin could play a role in motricity. The neuropeptide could act as a neuromodulator, because it would not directly activate motoneurons, but rather render them more responsive to incoming excitatory inputs. Vasopressin may thus act as a regulator of muscular force.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752783     DOI: 10.1046/j.1460-9568.2003.02625.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

1.  Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress.

Authors:  Britta Veitenheimer; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-01       Impact factor: 3.619

2.  Expression of arginine vasotocin receptors in the developing zebrafish CNS.

Authors:  Kenichi Iwasaki; Meari Taguchi; Joshua L Bonkowsky; John Y Kuwada
Journal:  Gene Expr Patterns       Date:  2013-07-02       Impact factor: 1.224

3.  Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse.

Authors:  Ara Schorscher-Petcu; Susana Sotocinal; Sorana Ciura; Anouk Dupré; Jennifer Ritchie; Robert E Sorge; Jacqueline N Crawley; Shuang-Bao Hu; Katsuhiko Nishimori; Larry J Young; Eliane Tribollet; Rémi Quirion; Jeffrey S Mogil
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

4.  Vasopressin indirectly excites dorsal raphe serotonin neurons through activation of the vasopressin1A receptor.

Authors:  B D Rood; S G Beck
Journal:  Neuroscience       Date:  2013-12-15       Impact factor: 3.590

5.  Nanomolar oxytocin synergizes with weak electrical afferent stimulation to activate the locomotor CpG of the rat spinal cord in vitro.

Authors:  Francesco Dose; Patrizia Zanon; Tamara Coslovich; Giuliano Taccola
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

6.  Developmental change and sexual difference in synaptic modulation produced by oxytocin in rat substantia gelatinosa neurons.

Authors:  Chang-Yu Jiang; Tsugumi Fujita; Eiichi Kumamoto
Journal:  Biochem Biophys Rep       Date:  2016-06-15

Review 7.  Cellular Mechanisms for Antinociception Produced by Oxytocin and Orexins in the Rat Spinal Lamina II-Comparison with Those of Other Endogenous Pain Modulators.

Authors:  Eiichi Kumamoto
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.